Lubricants are a non-negotiable part of tablet formulation. Its main role is ensuring clean compression by reducing friction between the tablet and the punch, enhance powder flowability and facilitating tablet ejection: a critical step that defines the entire batch viability.
Magnesium stearate remains the most widely used lubricant in the industry. Well documented, reliable and effective even in small amounts, this lubricant is the go-to choice for formulators.
Yet formulation is rarely one-size-fits-all. Understanding why lubricants matter, what magnesium stearate brings to the table, and when an alternative might better serve your needs is key for formulation performance.
Magnesium Stearate: historical efficiency
Magnesium stearate (MGS) is the industry benchmark lubricant because of its consistent performance and broad formulation compatibility. This substance is a salt of stearic acid (a long chain fatty acid) employed as a lubricant in pharmaceutical tablet and capsule manufacturing. This hydrophobic salt reduces die wall friction, lowers ejection forces, and limits equipment wear, while also improving powder flowability for better die filling, weight consistency, and content uniformity.
However, its hydrophobic nature requires careful concentration and blending time management. This means that mostly API that are lipophile are magnesium stearate safe. Moreover, excess MGS or overmixing can lead to over-lubrication and reduced tablet hardness. Furthermore, by forming a water-repellent film around particles, MGS can slow dissolution and disintegration of the tablet, potentially limiting API bioavailability.
Among the magnesium stearate available on the market, the FARMAL® MGS is particularly process-resilient due to its high performance for a very small amount (typically ~0.25–2%) while remaining compatible with most APIs and excipient. This key advantage allows the formulator to manage risk associated with process parameters.
Sodium Stearyl Fumarate: formulation versatility
While magnesium stearate remains the industry standard, sodium stearyl fumarate (SSF) is an interesting alternative when robustness, dissolution performance, and API compatibility are priorities. That lubricant can also be used to enhance powder flow in capsule manufacturing.
SSF is derived from stearic acid and fumaric acid. Thanks to its charged sodium carboxylate group and a fumarate-derived polar portion that can interact with water this amphiphilic molecule acts as a hydrophilic lubricant. That ionic head group dominates the surface behavior enough to make it a hydrophilic tablet lubricant.
Therefore, it does not form a water-repelling film around tablet particles. Instead, it allows water to reach the tablet core faster, supporting quicker wetting, disintegration, and more consistent dissolution.
For APIs with limited solubility, where absorption depends on efficient dissolution, this represents a key advantage. Faster, more reliable dissolution means more predictable drug release and better bioavailability.
From a process perspective, SSF like FARMAL®SSF offers a high degree of flexibility in blending time. As over-blending is a common lubrication challenge, this broader tolerance can help manufacturers maintain consistent tablet quality while making the process easier to manage.
All of this makes SSF a go-to choice for:
- Poorly soluble APIs where dissolution is already a bottleneck
- ODTs that need to break up fast
- Effervescent system
- Moisture-sensitive APIs incompatible with other lubricants (Louw,2003)
These properties are well established in literature, but what do they look like in practice? Here is what our application laboratory work revealed.
From Literature to Real Life Result: Case study of FARMAL® MGS and FARMAL® SSF
From a regulatory standpoint, both lubricants are widely approved (USP-NF, Ph. Eur. Specifications). The limits start at compatibility: FARMAL®SSF has typically a broader compatibility across formulations and API, while Magnesium stearate can be limited by its hydrophobic properties.
Three key parameters are affected differently depending on the lubricant.
Lubrication efficiency
A higher transmission coefficient is observed when using FARMAL® SSF compared to FARMAL® MGS indicating that less energy is lost to friction at the die wall, proof of a more effective lubrication of the system. This improved lubrication reduces resistance during compaction. Thus, better lubricating properties contribute to improved tablet uniformity and lower risk of defects due to product sticking to manufacturing equipment.
Ejection force directly reflects the friction between the tablet and the die wall at the end of compression. Lower ejection forces with FARMAL® SSF indicate more effective lubrication at this critical stage.
This facilitates smoother tablet ejection and reduces the risk of defects such as sticking, picking, or capping. It also limits wear on punches and dies, contributing to improved equipment longevity.
Blending time sensitivity
Finally, the key competitive advantage of FARMAL® SSF: minimal to no sensibility to blending time. This is particularly advantageous during scale-up or in environments where tight control of mixing parameters is challenging.
Additionally, because SSF does not significantly hinder water penetration, disintegration and dissolution performance remain more stable, supporting consistent API release.
Optimizing formulation with magnesium stearate: a more sustainable approach
For many APIs, magnesium stearate remains the only technically or regulatory viable lubricant. In today's pharmaceutical landscape, beyond performance, excipient choice increasingly intersects with sustainability and a more responsible approach means prioritizing direct compression over wet granulation where possible and selecting multifunctional excipients that reduce overall formula complexity.
Our application lab put this principle into practice. Using MANNITAB™ SD2 , a spray-dried mannitol well suited for ODT and chewable tablets, highly water-soluble and direct-compression ready, combined with FARMAL® MGS as lubricant, we compared three formulations varying only in binder: two market references and UNI-PURE®WG220, a pregelatinized corn starch.
The study was conducted under controlled conditions, with all formulation and process parameters kept constant (e.g., excipient proportions, tablet size) to ensure robust and unbiased comparison.
The pregelatinized starch required lower or equal ejection forces, reflecting better compressibility and less mechanical stress on the tooling.
More strikingly, it showed minimal impact on disintegration time, eliminating the need for a dedicated disintegrant altogether. Compared to the reference binders, UNI-PURE WG 220 achieves disintegration times up to ten times shorter.
Compared to market references, UNI-PURE WG 220 delivered equivalent compression performance with a leaner, simpler formula.
From a sustainability standpoint, UNI-PURE WG 220 enables a simpler tablet design, fewer processing steps, and lower total Scope 3 emissions through reduced materials, energy, and waste, while ensuring optimal tablet quality.
Conclusion
While magnesium stearate remains a reliable workhorse of tablet lubrication, today’s formulation challenges call for more than routine selection. Whether optimizing an existing formulation or developing a new one, understanding when to rely on established solutions and when to explore alternatives is essential to achieving robust and scalable results.
At Safic-Alcan, we are proud to support this transformation. This is why we have partnered with Ingredion Pharma Solutions, a company that offers functional excipients to enhance the performance of formulations and overcome technical challenges. We can help you move beyond routine approaches toward smarter formulation design and optimized outcomes.